Metraipolis › archive › dc_31eb46d09f2b

Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a… — Europe PMC PMID:42147217

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42147217
DOI
10.3389/fonc.2026.1770835
License (as archived)
solo-consultazione
Archived
2026-11-02T23:49:13.670Z
SHA-256 of the archived text
11dc0c9c0b0e7f9e747e7b9f33510d6ef5a484e5053445524855bb81a8aac8ab
Stable URL of this page
https://metraipolis.com/documento/dc_31eb46d09f2b

How to cite

Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a… — Europe PMC PMID:42147217 — Europe PMC (en), https://europepmc.org/article/MED/42147217 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_31eb46d09f2b (Metraipolis archive dc_31eb46d09f2b, sha256 11dc0c9c0b0e7f9e747e7b9f33510d6ef5a484e5053445524855bb81a8aac8ab)
BibTeX
@misc{dc31eb46d09f2b,
  title = {Efficacy and safety of deep hyperthermia combined with tislelizumab and chemotherapy in the treatment of advanced squamous non-small-cell lung cancer: a… — Europe PMC PMID:42147217},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42147217},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_31eb46d09f2b; sha256 11dc0c9c0b0e7f9e747e7b9f33510d6ef5a484e5053445524855bb81a8aac8ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147217. Agents can read the archived copy with the MCP tool read_document.